BNP Paribas Financial Markets
ASTX

BNP Paribas Financial Markets’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-51,782
Closed -$440K – 4212
2013
Q3 		$440K Buy
51,782
+18,160
+54% +$115K ﹤0.01% 1622
2013
Q2 		$138K Buy
+33,622
New +$181K ﹤0.01% 2469

BNP Paribas Financial Markets's ASTX Position: Q4 2013 in Review

BNP Paribas Financial Markets sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 51,782 shares — an estimated $440K sold.

BNP Paribas Financial Markets first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $440K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BNP Paribas Financial Markets reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 51,782 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $440K.
  • BNP Paribas Financial Markets first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BNP Paribas Financial Markets's ASTEX PHARMACEUTICALS, INC COM position peaked at $440K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.